Portal de Periódicos da CAPES

Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura

2007; Elsevier BV; Volume: 127; Issue: 3 Linguagem: Inglês

10.1016/j.ijcard.2007.05.075

1874-1754

María Cruz Ferrer Gracia, Isabel Calvo Cebollero, Juan Sánchez-Rubio Lezcano, Gabriel Galache Osuna, José A. Diarte de Miguel, Luis Placer Peralta,

Heparin-Induced Thrombocytopenia and Thrombosis

Acute myocardial infarction (AMI) is infrequent in patients with idiopathic thrombocytopenic purpura (ITP) so the best treatment is not well known. The next case shows a 37-year-old man with chronic ITP who suffered an anterior AMI, the platelet count at admission was 39,000 μL. He was treated successfully with primary percutaneous angioplasty under anticoagulation with unfractionated heparin and antiaggregation with clopidogrel and ASA. At the end of the procedure we sealed the femoral access site with Angio-Seal®. He didn´t have any complications during the procedure and after six months remained asymptomatic. In some patients with chronic ITP and AMI the percutaneous treatment could be a good option.